1-methyl-1H-pyrazol-3-yl derivatives for use in the treatment of neovascular diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 12024504
APP PUB NO 20220411412A1
SERIAL NO

17817136

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Anti-angiogenic treatments and compounds for use in anti-angiogenic treatments, particularly of conditions associated with abnormal angiogenesis or abnormal over-production of pro-angiogenic VEGFxxx isoforms in or on the eye are described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EXONATE LIMITEDCAMBRIDGE CAMBRIDGESHIRE CB22 4PS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baxter, Andrew Douglas Horsham, GB 71 368
Morris, Jonathan Sydney, AU 49 1870

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jan 2, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 2, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 2, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00